Woman looking up and to the side on a geometric background.

Frequently Asked Questions About Opill® and Contraception Access

Stopping Opill®

What if I want to become pregnant while taking Opill®?
Opill® does not delay your ability to get pregnant once you choose to stop taking it.
›
What happens if I want to stop taking Opill®?
You can choose to stop Opill® whenever you want! Once you stop taking Opill®, you are no longer protected against pregnancy.
›

More information by topic


What is Opill®
Buying Opill®
Taking Opill®
Opill® and your health
Side effects and interactions



References

[1] U.S. Food and Drug Administration. (2023, July 14). Opill (0.075mg Oral Norgestrel Tablet) Information. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-andproviders/opill-0075mg-oral-norgestrel-tablet-information

[2] Worly BL, Gur TL, Schaffir J. The relationship between progestin hormonal contraception and depression: a systematic review. Contraception. 2018 Jun;97(6):478-489. doi: 10.1016/j.contraception.2018.01.010. Epub 2018 Feb 26. PMID: 29496297.

[3] Lee IT, Barnhart KT. What Is an Ectopic Pregnancy? JAMA. 2023;329(5):434. doi:10.1001/jama.2022.22941

[4] Planned Parenthood. What is ectopic pregnancy?: Definition and treatment. Ectopic Pregnancy.Retrieved November 17, 2023, from https://www.plannedparenthood.org/learn/pregnancy/ectopic-pregnancy.

[5] Lopez LM, Ramesh S, Chen M, Edelman A, Otterness C, Trussell J, Helmerhorst FM. Progestin-only contraceptives: effects on weight. Cochrane Database Syst Rev. 2016 Aug 28;2016(8):CD008815. doi:10.1002/14651858.CD008815.pub4. PMID: 27567593; PMCID: PMC5034734.

[6] Graham CA, Ramos R, Bancroft J, Maglaya C, Farley TM. The effects of steroidal contraceptives on the well-being and sexuality of women: a double-blind, placebo-controlled, two-centre study of combined and progestogen-only methods. Contraception. 1995 Dec;52(6):363-9. doi:10.1016/0010-7824(95)00226-x. PMID: 8749600.

[7] Curtis KM et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2016. MMWR Recomm Rep 2016;65(No. RR-3):1–104. DOI: http://dx.doi.org/10.15585/mmwr.rr6503a1Curtis KM et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2016. MMWR Recomm Rep 2016;65(No. RR-3):1–104. doi:http://dx.doi.org/10.15585/mmwr.rr6503a1-8-